Amantadine and interferon for treatment of chronic hepatitis C - A preliminary analysis.

被引：0
|
作者：
Ben-Ari, Z
Zemel, R
Kazatzker, A
Manhaim, V
Tur-Kaspa, R
机构：
[1] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
[2] Felsenstein Med Res Ctr, Petah Tiqwa, Israel
[3] Rabin Med Ctr, Dept Med D, Liver Inst, Petah Tiqwa, Israel
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2136
引用
收藏
页码：696A / 696A
页数：1
相关论文
共 50 条
  • [31] Amantadine plus interferon is not effective in non responder to interferon chronic hepatitis C patients.
    Diago, M
    Perez-Anton, C
    García, V
    Carbonell, P
    Cors, R
    Aznar, V
    Martinez, M
    Andreu, J
    HEPATOLOGY, 1999, 30 (04) : 629A - 629A
  • [32] Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine
    Pérez-Alvarez, R
    Pérez-López, R
    Lombraña, JLS
    Rodríguez, M
    Rodrigo, L
    JOURNAL OF VIRAL HEPATITIS, 2002, 9 (01) : 75 - 79
  • [33] Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C
    Zobair M. Younossi
    Arthur C. McCullough
    David S. Barnes
    Anthony Post
    Janus P. Ong
    Robert O’shea
    Lisa M. Martin
    Diane Bringman
    Denise Farmer
    Gavin Levinthal
    Kevin D. Mullen
    William D. Carey
    Anthony S. Tavill
    Roy Ferguson
    Terry Gramlich
    Digestive Diseases and Sciences, 2005, 50 : 970 - 975
  • [34] Pegylated interferon α-2b, ribavirin and amantadine for chronic hepatitis C
    Younossi, ZM
    McCullough, A
    Barnes, D
    Post, A
    Ong, J
    O'Shea, R
    Martin, LM
    Bringman, D
    Farmer, D
    Levinthal, G
    Mullen, KD
    Carey, WD
    Tavill, AS
    Ferguson, R
    Gramlich, T
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (05) : 970 - 975
  • [35] Interferon α, ribaivirin and amantadine combination is effective therapy for chronic hepatitis C.
    Sperl, J
    Hejtmankova, S
    Taimr, P
    Trunecka, P
    Honsova, E
    Spicak, J
    HEPATOLOGY, 2002, 36 (04) : 570A - 570A
  • [36] Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon nonresponsive chronic hepatitis C: a randomised trial
    Adinolfi, LE
    Utili, R
    Tonziello, A
    Ruggiero, G
    GUT, 2003, 52 (05) : 701 - 705
  • [37] A randomised, open label, controlled trial on the effect of interferon plus amantadine compared with interferon alone for treatment of chronic hepatitis C
    Baisini, O
    Pigozzi, MG
    Benini, F
    Stellini, R
    Reggiani, A
    Quattrocchi, D
    Salmi, A
    Andri, G
    Cominotti, A
    Favret, M
    Gargiulo, F
    Lanzini, A
    HEPATOLOGY RESEARCH, 2003, 26 (03) : 167 - 173
  • [38] Combination therapy interferon plus amantadine in chronic active hepatitis C. A multicentric randomised study: Preliminary reports
    Tabone, M
    Del Mastro, B
    Bonardi, R
    Andreoni, M
    Manca, A
    Calleri, G
    Cariti, G
    Cusumano, S
    Brunello, F
    HEPATOLOGY, 1999, 30 (04) : 628A - 628A
  • [39] No beneficial effects of amantadine in treatment of chronic hepatitis C patients
    van Soest, Hanneke
    van der Schaar, Peter J.
    Koek, Ger H.
    de Vries, Richard A.
    van Ooteghem, Nancy A.
    van Hoek, Bart
    Drenth, Joost P. H.
    Vrolijk, Jan M.
    Lieverse, Rob J.
    Houben, Peter
    Veer, Annet van der Sluys
    Siersema, Peter D.
    Schipper, Marguerite E. I.
    van Erpecum, Karel J.
    Boland, Greet J.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (07) : 496 - 502
  • [40] Treatment of chronic hepatitis C with amantadine hydrochloride in children.
    Mousa, H
    Reyes, J
    Sakallah, S
    Jaffe, R
    Kocoshis, S
    HEPATOLOGY, 1998, 28 (04) : 709A - 709A
12345